Tower Research Capital (TRC)’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$386K Buy
6,111
+5,053
+478% +$319K 0.01% 1197
2025
Q1
$56K Sell
1,058
-3,481
-77% -$184K ﹤0.01% 2152
2024
Q4
$254K Buy
4,539
+4,161
+1,101% +$233K 0.01% 1553
2024
Q3
$19.8K Sell
378
-9,547
-96% -$500K ﹤0.01% 3243
2024
Q2
$408K Buy
9,925
+9,386
+1,741% +$385K 0.01% 1504
2024
Q1
$23.4K Sell
539
-9,169
-94% -$397K ﹤0.01% 2863
2023
Q4
$446K Buy
9,708
+8,764
+928% +$403K 0.01% 1451
2023
Q3
$21.6K Sell
944
-2,806
-75% -$64.3K ﹤0.01% 3298
2023
Q2
$61.8K Sell
3,750
-13,463
-78% -$222K ﹤0.01% 2393
2023
Q1
$307K Buy
17,213
+3,463
+25% +$61.8K 0.01% 1126
2022
Q4
$400K Buy
13,750
+5,276
+62% +$153K 0.02% 831
2022
Q3
$207K Buy
8,474
+2,670
+46% +$65.2K ﹤0.01% 1905
2022
Q2
$25K Sell
5,804
-28,704
-83% -$124K ﹤0.01% 3573
2022
Q1
$397K Buy
34,508
+31,990
+1,270% +$368K ﹤0.01% 1288
2021
Q4
$25K Sell
2,518
-679
-21% -$6.74K ﹤0.01% 3435
2021
Q3
$41K Sell
3,197
-538
-14% -$6.9K ﹤0.01% 3118
2021
Q2
$73K Buy
3,735
+1,461
+64% +$28.6K ﹤0.01% 2692
2021
Q1
$48K Buy
2,274
+1,490
+190% +$31.5K ﹤0.01% 3161
2020
Q4
$23K Sell
784
-1,233
-61% -$36.2K ﹤0.01% 3781
2020
Q3
$44K Sell
2,017
-767
-28% -$16.7K ﹤0.01% 3586
2020
Q2
$62K Buy
+2,784
New +$62K ﹤0.01% 2881
2019
Q4
Sell
-603
Closed -$13K 4258
2019
Q3
$13K Buy
+603
New +$13K ﹤0.01% 2783
2019
Q2
Sell
-1,095
Closed -$30K 4199
2019
Q1
$30K Buy
1,095
+859
+364% +$23.5K ﹤0.01% 2045
2018
Q4
$7K Buy
236
+187
+382% +$5.55K ﹤0.01% 2707
2018
Q3
$1K Sell
49
-375
-88% -$7.65K ﹤0.01% 3614
2018
Q2
$13K Buy
424
+32
+8% +$981 ﹤0.01% 2671
2018
Q1
$8K Buy
+392
New +$8K ﹤0.01% 2562